Role of leukotrienes and platelet activating factor in gastric mucosal damage and repair
- PMID: 1782413
Role of leukotrienes and platelet activating factor in gastric mucosal damage and repair
Abstract
Gastric mucosal integrity depends upon the balance between "aggressive" factors and "defensive" mechanisms. The formation of mucosal lesions results from the disruption of defense lines, including the breaking of unstirred mucus layer, the reduction of surface hydrophobicity, extensive exfoliation of surface epithelium, penetration of offending agents deeply into the mucosa and damage to the microvessels. The release of proinflammatory and vasoactive mediators such as leukotrienes (LT), thromboxanes, platelet activating factor (PAF), endothelins and others has been thought to be involved in the pathomechanism of mucosal injury, especially damage to the microvascular endothelium, increased vascular permeability, reduction in mucosal blood flow, vascular stasis, tissue ischemia and glandular cell necrosis. This paper reviews the mechanisms and possible pathogenetic implication of two related compounds, LT and PAF in acute mucosal injury by topical irritants such as ethanol, aspirin, bile salts and by stress. LT and PAF arise from similar membrane phospholipids and may regulate the biosynthesis of one another in the damaged mucosa. Although pharmacological studies have clearly demonstrated the noxious effects of cysteinyl LT and PAF on the mucosa, especially when exposed to topical irritants, recent publications have challenged the primary role of these mediators in the pathogenesis of mucosal lesions and ulcerations because the treatment with agents that selectively antagonize their biosynthesis or the receptor sites at the target cells did not always interrupt the chain of events leading to mucosal injury. The role of these mediators in the mucosal repair processes has been little studied but both cysteinyl LT and PAF seem to delay the restitution and healing of the mucosa. Further studies are necessary to clarify to what extent the biosynthesis of LT and PAF and the pharmacological inhibition of their action on the target tissues is related to noxious, protective and reparative events in the mucosa exposed to mild irritants and ulcerogens.
Similar articles
-
[Gastro-protection in vivo and in vitro].Patol Pol. 1992;43(1):1-9. Patol Pol. 1992. PMID: 1296166 Review. Polish.
-
Leukotrienes in mucosal damage and protection.J Physiol Pharmacol. 1991 Jun;42(2):135-45. J Physiol Pharmacol. 1991. PMID: 1782414
-
Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.Eur J Pharmacol. 1989 May 19;164(2):285-92. doi: 10.1016/0014-2999(89)90469-x. Eur J Pharmacol. 1989. PMID: 2759176
-
Actions and interactions of endothelins, prostacyclin and nitric oxide in the gastric mucosa.J Physiol Pharmacol. 1993 Jun;44(2):91-107. J Physiol Pharmacol. 1993. PMID: 8358055 Review.
-
Physiological, immunohistochemical and molecular aspects of gastric adaptation to stress, aspirin and to H. pylori-derived gastrotoxins.J Physiol Pharmacol. 1997 Mar;48(1):3-42. J Physiol Pharmacol. 1997. PMID: 9098824 Review.
Cited by
-
Role of platelet-activating factor in acid-induced esophageal mucosal injury.Dig Dis Sci. 2007 Aug;52(8):1861-6. doi: 10.1007/s10620-006-9385-9. Epub 2007 Apr 6. Dig Dis Sci. 2007. PMID: 17415649
-
The role of phospholipase A2 in calcium-ionophore-mediated injury to rat gastric mucosal cells.Dig Dis Sci. 1999 Mar;44(3):494-502. doi: 10.1023/a:1026688819939. Dig Dis Sci. 1999. PMID: 10080140
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical